I'm LongbridgeAI, I can summarize articles.In Wednesday's intraday session, several health care stocks experienced significant movements. Larimar Therapeutics (LRMR) surged 58.4% to $5.84, while Cardio Diagnostics (CDIO) rose 26.13% to $4.17. Acadia Healthcare (ACHC) and NovoCure (NVCR) saw increases of 23.99% and 23.55%, respectively. Conversely, CASI Pharmaceuticals (CASI) plummeted 57.7% to $0.34, with MannKind (MNKD) and 20/20 Biolabs (AIDX) also facing declines of 37.1% and 30.83%. The Q4 earnings reports were released today for several companies.
Gainers
- Larimar Therapeutics (NASDAQ:LRMR) shares moved upwards by 58.4% to $5.84 during Wednesday's regular session. The company's market cap stands at $306.6 million.
- Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock moved upwards by 26.13% to $4.17. The company's market cap stands at $6.0 million.
- Acadia Healthcare Co (NASDAQ:ACHC) stock rose 23.99% to $21.29. The company's market cap stands at $1.5 billion. The company's, Q4 earnings came out today.
- NovoCure (NASDAQ:NVCR) stock increased by 23.55% to $14.51. The company's market cap stands at $1.3 billion.
- VolitionRX (AMEX:VNRX) shares increased by 20.6% to $0.23. The company's market cap stands at $26.2 million.
- C4 Therapeutics (NASDAQ:CCCC) stock rose 18.84% to $2.84. The company's market cap stands at $222.4 million.
Losers
- CASI Pharmaceuticals (NASDAQ:CASI) stock declined by 57.7% to $0.34 during Wednesday's regular session. The market value of their outstanding shares is at $12.3 million.
- MannKind (NASDAQ:MNKD) shares fell 37.1% to $3.48. The company's market cap stands at $1.6 billion.
- 20/20 Biolabs (NASDAQ:AIDX) shares fell 30.83% to $5.52. The market value of their outstanding shares is at $82.5 million.
- Geron (NASDAQ:GERN) stock fell 18.72% to $1.58. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q4 earnings came out today.
- Ironwood Pharmaceuticals (NASDAQ:IRWD) shares fell 18.47% to $3.09. The market value of their outstanding shares is at $616.5 million. As per the news, the Q4 earnings report came out today.
- Gossamer Bio (NASDAQ:GOSS) stock decreased by 16.86% to $0.35. The company's market cap stands at $96.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.